Vertex Pharmaceuticals (VRTX)

R&D to Revenue

29.81%

Quarterly · Period ending:

VRTX logo

VRTX R&D to Revenue

Latest reported29.81%
VRTX Quarterly R&D/Revenue (0.00% → 29.81%)
High-resolution chart · PNG

VRTX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals R&D to Revenue — Quarterly
Period endingR&D to Revenue
129.6181%
137.0572%
127.6137%
153.9593%
53.5292%
247.295%
61.1486%
170.8333%
124.183%
465%
154.7009%
85.3261%
175%
381.25%
125%
121.4815%
88.5246%
149.2754%
164.5833%
293.1034%
306.4516%
372%
102.439%
373.913%
232.3077%
184.3137%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.